KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Operating Income (2016 - 2026)

Medtronic's Operating Income history spans 13 years, with the latest figure at $1.5 billion for Q1 2026.

  • For Q1 2026, Operating Income fell 11.06% year-over-year to $1.5 billion; the TTM value through Jan 2026 reached $6.0 billion, up 8.24%, while the annual FY2025 figure was $6.0 billion, 15.77% up from the prior year.
  • Operating Income for Q1 2026 was $1.5 billion at Medtronic, down from $1.7 billion in the prior quarter.
  • Across five years, Operating Income topped out at $1.7 billion in Q4 2025 and bottomed at $1.1 billion in Q2 2024.
  • The 5-year median for Operating Income is $1.4 billion (2025), against an average of $1.4 billion.
  • The largest annual shift saw Operating Income crashed 32.72% in 2024 before it soared 36.37% in 2025.
  • A 5-year view of Operating Income shows it stood at $1.4 billion in 2022, then decreased by 4.56% to $1.3 billion in 2023, then grew by 19.03% to $1.6 billion in 2024, then increased by 5.71% to $1.7 billion in 2025, then decreased by 13.17% to $1.5 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Operating Income are $1.5 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.4 billion (Q3 2025).